Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.
about
Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a reviewProbiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseasesReview of current methods for characterizing virulence and pathogenicity potential of industrial Saccharomyces cerevisiae strains towards humansProbiotics, prebiotics and synbiotics- a reviewSaccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticumProbiotics for vaginal health in South Africa: what is on retailers' shelves?Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases?Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii.S-Adenosyl-L-methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell death.A review of the economics of treating Clostridium difficile infection.Oral administration of Saccharomyces boulardii ameliorates carbon tetrachloride-induced liver fibrosis in rats via reducing intestinal permeability and modulating gut microbial composition.Oral administration of Bifidobacterim bifidum for modulating microflora, acid and bile resistance, and physiological indices in mice.Novel approaches to treating Clostridium difficile-associated colitis.Efficacy of oral Bifidobacterium bifidum ATCC 29521 on microflora and antioxidant in mice.Evaluation of probiotic potential of yeasts isolated from traditional cheeses manufactured in Serbia and Croatia.Antimicrobial and antioxidant activities of Saccharomyces cerevisiae IFST062013, a potential probioticEfficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.Infant fungal communities: current knowledge and research opportunities.Comparison of Two Forms of Loperamide-Simeticone and a Probiotic Yeast (Saccharomyces boulardii) in the Treatment of Acute Diarrhoea in Adults: A Randomised Non-Inferiority Clinical Trial.Blastocystis: Consensus of treatment and controversies.Dynamic In Vitro Models of the Human Gastrointestinal Tract as Relevant Tools to Assess the Survival of Probiotic Strains and Their Interactions with Gut Microbiota.Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature.Probiotics and prebiotics in pediatric diarrheal disorders.Saccharomyces boulardii CNCM I-745 in different clinical conditions.Production and Biomedical Applications of Probiotic Biosurfactants.The Saccharomyces boulardii CNCM I-745 strain shows protective effects against the B. anthracis LT toxinImproving health from the inside: Use of engineered intestinal microorganisms as in situ cytokine delivery system.Efficacy and Safety of Saccharomyces boulardii in Acute Rotavirus Diarrhea: Double Blind Randomized Controlled Trial from a Developing Country.Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.Synergistic effects of fenbendazole and metronidazole against Giardia muris in Swiss mice naturally infected.Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.Probiotic yeast Saccharomyces boulardii (nom. nud.) modulates adhesive properties of Candida glabrata.Modulation of IL-12 and IFNγ by probiotic supplementation promotes protection against Toxocara canis infection in mice.Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea.Gleaning evolutionary insights from the genome sequence of a probiotic yeast Saccharomyces boulardii.Effect of a Lactobacillus Salivarius Probiotic on a Double-Species Streptococcus Mutans and Candida Albicans Caries Biofilm.Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients.Improved antimicrobial activity of Pediococcus acidilactici against Salmonella Gallinarum by UV mutagenesis and genome shuffling.Influence of freezing temperatures prior to freeze-drying on viability of yeasts and lactic acid bacteria isolated from wine.
P2860
Q26796416-0F38F396-B429-4810-9ADB-6B9362FBD628Q26800020-43089F2D-5F66-445E-AB7A-91CF10357C66Q26801516-EABFE538-0DB0-45CE-B7D9-5FC4D1B5E2E6Q28087443-E03B7FBE-BC16-4C94-93E6-85EF6553AA94Q28236940-FDCC4E88-E34B-4AD1-B5F1-E2E56FC3CEFBQ30835665-CDCE623D-5AFD-4246-AD32-4158644E5DC4Q34286137-89C1D494-76F8-4951-9724-BCED552D312CQ34487166-91166F5B-5110-4B54-BE10-8A6597B78A6AQ34554028-3A00D592-86DF-4BE7-928B-6DC0BAA52F99Q34583104-4A907952-D2A8-43D5-B33E-EF871CB48570Q35164905-7447400F-564F-4C45-ADBF-05B7FF42C015Q35256601-F941F7C3-948F-470C-A90D-1E69CFD813DFQ35550821-D10BC986-34F4-4EB9-A59E-DEA70C10D90DQ35862915-67B11763-6AC4-4136-A457-9F04894EB623Q35919704-85E19E46-CAD7-4C89-A1AB-536EA0DECDAAQ36051017-2A6ABC01-9EA4-45AA-A44C-E32D9D81733BQ36256310-232CC0B9-8A83-40B0-B7A3-3E71696129CDQ36271872-D72AE482-AA4E-4D50-8288-277773133EC5Q36278070-6792DBFC-F34C-4AFB-98ED-7687FE8E7AE8Q36327809-D32D5B5B-0CCD-49AF-A6CC-8FA086CE01DFQ37100469-4453B83D-BFD0-4F71-98AF-B69BD8234D5BQ37255990-0F908892-E40E-47B3-AE4E-A0374F22DD83Q37676927-5E2594E4-7DC2-4EF6-9302-4F2D6780E7FBQ38081229-14A25A15-8C6A-4364-A631-CDF4E37F00E2Q38226331-3F00D798-1B7E-44E3-BAE1-C5C0C800BBA1Q38689709-47A9B40F-A4AE-4EE2-A82B-BA4FD9D2E372Q38822566-56AB4B5C-C15E-4E4A-BDBC-A62745EB757AQ39251357-0CFF7516-409D-4969-A3F7-E6459AAB64C1Q40101950-92447A7F-CA26-403B-AC8A-4E0798492323Q40113239-0134C2D8-6A33-4968-9361-EC9B880B1671Q40389822-F7A7E915-0627-41C2-B998-9AE4AF9B715DQ40579622-21CC55AC-E9B8-4866-98BE-DD9F8F23D388Q40649724-930AD2BC-CF4F-4FF0-9751-9FB93AA8166DQ40757760-82830642-B556-4774-B5BA-348A94D41A92Q41502760-CA0B9355-CC84-4ECD-8CDD-A4D377C02B0DQ42099613-9543AFEA-EC47-4405-812D-37AB125E1811Q46261727-B258D395-3E14-43A1-A08A-B3497A1524A7Q46300594-09323186-2719-420C-BEE6-AB467C38C931Q46372148-1C370C62-04C6-4ED4-9C6A-209233BB6547Q46390353-119D1BD9-2C10-4C53-994D-EF2366559F7D
P2860
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Efficacy and safety of the pro ...... of gastrointestinal disorders.
@en
Efficacy and safety of the pro ...... of gastrointestinal disorders.
@nl
type
label
Efficacy and safety of the pro ...... of gastrointestinal disorders.
@en
Efficacy and safety of the pro ...... of gastrointestinal disorders.
@nl
prefLabel
Efficacy and safety of the pro ...... of gastrointestinal disorders.
@en
Efficacy and safety of the pro ...... of gastrointestinal disorders.
@nl
P2860
P356
P1476
Efficacy and safety of the pro ...... of gastrointestinal disorders.
@en
P2093
Charalabos Pothoulakis
P2860
P304
P356
10.1177/1756283X11428502
P577
2012-03-01T00:00:00Z